GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » Market Cap

ME Therapeutics Holding (FRA:Q9T) Market Cap : €70.20 Mil (As of Dec. 15, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ME Therapeutics Holding's share price for the quarter that ended in Aug. 2024 was €1.7. ME Therapeutics Holding's Shares Outstanding (EOP) for the quarter that ended in Aug. 2024 was 25.19 Mil. Therefore, ME Therapeutics Holding's market cap for the quarter that ended in Aug. 2024 was €42.82 Mil.

ME Therapeutics Holding's quarterly market cap increased from Feb. 2024 (€19.03 Mil) to May. 2024 (€60.45 Mil) but then declined from May. 2024 (€60.45 Mil) to Aug. 2024 (€42.82 Mil).

ME Therapeutics Holding's annual market cap stayed the same from Aug. 2022 (€0.00 Mil) to Aug. 2023 (€0.00 Mil) but then increased from Aug. 2023 (€0.00 Mil) to Aug. 2024 (€42.82 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ME Therapeutics Holding's Enterprise Value for Today is €69.97 Mil.

ME Therapeutics Holding Market Cap Historical Data

The historical data trend for ME Therapeutics Holding's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Market Cap Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23 Aug24
Market Cap
- - 42.82

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24 May24 Aug24
Market Cap Get a 7-Day Free Trial - - 19.03 60.45 42.82

Competitive Comparison of ME Therapeutics Holding's Market Cap

For the Biotechnology subindustry, ME Therapeutics Holding's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Market Cap distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Market Cap falls into.


ME Therapeutics Holding Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

ME Therapeutics Holding's Market Cap for the fiscal year that ended in Aug. 2024 is calculated as

Market Cap (A: Aug. 2024 )=Share Price (A: Aug. 2024 )*Shares Outstanding (EOP) (A: Aug. 2024 )
=€1.7*25.1895
=€42.82

ME Therapeutics Holding's Market Cap for the quarter that ended in Aug. 2024 is calculated as

Market Cap (Q: Aug. 2024 )=Share Price (Q: Aug. 2024 )*Shares Outstanding (EOP) (Q: Aug. 2024 )
=€1.7*25.1895
=€42.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding  (FRA:Q9T) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

ME Therapeutics Holding Market Cap Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » Market Cap
Comparable Companies
Traded in Other Exchanges
METX:Canada
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines